Federated Hermes, Inc. Centogene N.V. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$9.02 - $12.93 $2.93 Million - $4.2 Million	-324,939 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$9.3 - $25.16 $574,656 - $1.55 Million	-61,791 Reduced 15.98%	324,939 $3.07 Million
Q2 2020 Aug 13, 2020	SELL	$15.99 - $22.88 $2.62 Million - $3.75 Million	-164,018 Reduced 29.78%	386,730 $8.85 Million
Q1 2020 May 13, 2020	SELL	$9.76 - $23.8 $178,686 - $435,730	-18,308 Reduced 3.22%	550,748 $11 Million
Q4 2019 Feb 14, 2020	BUY	$8.1 - $14.6 $4.61 Million - $8.31 Million	569,056 New	569,056 $5.73 Million

2.14M

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $10.3M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.